BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Alembic Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
533573
ISIN Demat
INE901L01018
Book Value (Rs)
304.2988178
NSE Symbol
APLLTD
Divident Yield %
1.24
Market Cap
(Rs In Cr.)
18,984
P/E (TTM)
18.63
EPS (TTM)
51.84
Face Value
(Rs)
2
Back
Alembic Pharmaceuticals consolidated net profit rises 81.46% in the September 2026 quarter
05-Nov-26   Hrs IST

Net profit of Alembic Pharmaceuticals rose 81.46% to Rs 335.17 crore in the quarter ended September 2026 as against Rs 184.71 crore during the previous quarter ended September 2025. Sales rose 36.30% to Rs 2603.48 crore in the quarter ended September 2026 as against Rs 1910.15 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales2603.481910.15 36
OPM %21.5816.53 -
PBDT538.75299.79 80
PBT437.95223.72 96
NP335.17184.71 81

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
BSE Delayed market data sourced at 5 minutes – www.bseindia.com
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)